Diagnostics & Pathology in India

Content

• 1. Industry & Market Overview

  • 1.1 Global medical and diagnostics laboratory
  • 1.2 Indian healthcare industry
    • 1.2.1 Market Size and Growth
    • 1.2.2 Healthcare infrastructure
    • 1.2.3 Overview of diagnostics & pathology laboratory industry
    • 1.2.4 Existing Business Models

• 2. Accreditations & Quality Control

  • 2.1 Introduction
  • 2.2 National Accreditation Board for Testing & Calibration Laboratories
  • 2.3 College for American Pathologist
    • 2.3.1 Benefits of CAP Accreditation
  • 2.4 Effect of the accreditation process among the clinical labs
    • 2.4.1 Quality manual
    • 2.4.2 Quality System Procedure
    • 2.4.3 Standard Test Operating Procedure (SOP)
    • 2.4.4 Records
    • 2.4.5. Quality control (Interlab/external)
    • 2.4.6. Internal audit
    • 2.4.7. Overall cost/expenses for Audit

• 3. Major Players

  • 3.1 Introduction
  • 3.2 Metropolis Health Services (India) Ltd.
    • 3.2.1. Company Background
    • 3.2.2. Contact Address
    • 3.2.3 Management Team
    • 3.2.4. Infrastructure & Accreditations
    • 3.2.5. Business Strategy & Competitive Advantages
    • 3.2.6. Outlook
  • 3.3 Religare SRL Diagnostics
    • 3.3.1. Company Background
    • 3.3.2. Contact Address
    • 3.3.3. Management Team
    • 3.3.4. Infrastructure & Accreditations
    • 3.3.5. Business Strategy & Competitive Advantages
    • 3.3.6. Outlook
  • 3.4 Piramal Diagnostics Services Pvt. Ltd. (PDSL)
    • 3.4.1. Company Background
    • 3.4.2. Contact Address:
    • 3.4.3. Management Team
    • 3.4.4. Infrastructure & Accreditations
    • 3.4.5. Business Strategy & Competitive Advantages
    • 3.4.6. Outlook
  • 3.5 Dr Lal Pathlabs
    • 3.5.1. Company Background
    • 3.5.2. Contact Address
    • 3.5.3. Management Team
    • 3.5.4. Infrastructure & Accreditations
    • 3.5.5. Business Strategy & Competitive Advantages
    • 3.5.6. Outlook
  • 3.6 Thyrocare
    • 3.6.1. Company Background
    • 3.6.2. Contact Address
    • 3.6.3. Management Team
    • 3.6.4. Infrastructure & Accreditations
    • 3.6.5. Business Strategy & Competitive Advantages
    • 3.6.6. Outlook
  • 3.7 Anand Labs
    • 3.7.1. Company Background
    • 3.7.2. Contact Address
    • 3.7.3. Management Team
    • 3.7.4. Infrastructure & ccreditations
    • 3.7.5. Business Strategy & Competitive Advantages
    • 3.7.6 Outlook
  • 3.8 Quest Diagnostics India Pvt. Ltd.
    • 3.8.1. Company Background
    • 3.8.2. Contact Address
    • 3.8.3. Management Team
    • 3.8.4. Infrastructure & Accreditations
    • 3.8.5. Business Strategy & Competitive Advantages
    • 3.8.6. Outlook

• 4. Growth Drivers

  • 4.1 Introduction
  • 4.2 Healthcare Institutes
    • 4.2.1 Foreign hospitals outsourcing diagnostics tests
    • 4.2.2 Polyclinics
    • 4.2.3 Pharmacies
    • 4.2.4 Medical KPO
  • 4.3 Healthcare Services
    • 4.3.1 CRO
    • 4.3.2 Molecular diagnostics
    • 4.3.3 Pharmacogenomics
  • 4.4 Theranostics, driving diagnostic test in drug development
  • 4.5 Logistics and Infrastructure
  • 4.6 IT Infrastructure and Network
  • 4.7 Insurance

• 5. Critical Success Factors

  • 5.1 Automation and standardisation
  • 5.2 Success of tests
  • 5.3 Processing blood samples
  • 5.4 Laboratory accreditation

• 6. Issues and Challenges

  • 6.1 Regulatory issues
  • 6.2 Reimbursement pressures
  • 6.3 Analytical and quality issues
  • 6.4 Accreditation procurement

• 7. Recent Trends

  • 7.1 Diagnostics Majors Mull over Outsourced Path Lab Management
  • 7.2 Consolidation in Diagnostics Services
  • 7.3 Diagnostics and Pathology Market Set to Flourish

• 8. Future Outlook

• Annexures

  • Annexure I Bibliography
  • Annexure II Glossary

• List of Tables

  • Table 1.1: Molecular Diagnostics Technologies
  • Table 1.2 Public healthcare physical infrastructure

• List of Figures

  • Figure 2.1: Indian Healthcare Market Size (FY03-FY08)
  • Figure 2.2: Healthcare Expenditure (2007)
  • Figure 2.3: Medical Devices & Diagnostics Market (2008)
  • Figure 2.4: Indian Diagnostics & Pathology Test Market (2005-2008)
  • Figure 2.5: Structure of Diagnostics & Pathology Labs Industry
  • Figure 2.6: Indian Diagnostics and Pathology Market (2008)
  • Figure 2.7: Indian Diagnostics and Pathological Test Market by Therapeutic Segment 2008
  • Figure 2.8: Referral Lab business model
  • Figure 8.1: Indian Diagnostic and Path Labs Market Forecast (2008-13)